Niskanen, Leo
Hahl, Jarmo
Haukka, Jari
Leppä, Elli
Miettinen, Tatu
Mushnikov, Vasili
Sipilä, Raija
Tamminen, Nadia
Vattulainen, Pia
Korhonen, Pasi
Funding for this research was provided by:
This study was financed by Pharma Industry Finland with direct grant to Epid Research Ltd. The writers contributing to this article did not receive any payments.
Article History
Received: 22 April 2018
Accepted: 25 July 2018
First Online: 6 August 2018
Compliance with ethical standards
:
: The authors declare conflicts of interest regarding this manuscript as follows: Leo Niskanen—no conflicts of interest regarding this manuscript. Hahl, Jarmo -Epid Research Ltd, Payment for contributing. Leppä, Elli—No conflict of interest. Miettinen, Tatu—Epid Research Ltd, Payment for contributing. Mushnikov, Vasili—Pharma Industry Finland, Payment to Epid Research Ltd. Jari Haukka, Vasili Mushnikov, Pia Vattulainen and Pasi Korhonen work for EPID Research. EPID Research is a contract research organization and thus its employees have been and currently are working in collaboration with several pharmaceutical companies.
: The whole study plan was approved by the Ethical Review Board of Helsinki University Hospital (HUS May 2013).
: This is a register-based study with anonymous data and no patient contacts. Thus no consents from anonymized patients were required according to Finnish law.